← FDA Drug Approvals (Drugs@FDA)

DOBUTAMINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HOSPIRA · Approved 1993-11-29

Drug application

FDA Application #

ANDA074086

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOBUTAMINE HYDROCHLORIDE

Generic name

DOBUTAMINE

Active ingredients

DOBUTAMINE HYDROCHLORIDE

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HOSPIRA

Manufacturer

Hospira, Inc.

First approval

1993-11-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown